Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: J Thromb Haemost. 2022 Jul 18;20(9):2035–2045. doi: 10.1111/jth.15777

Figure 5:

Figure 5:

Effects of pharmacologic targeting of FXI by 14E11 on CD31 staining. CD31 immunostaining of saline- vs 14E11-treated animals on days 3 and 7 post IVC constriction at 4x (scale bar=0.5 mm) (A). Quantification of cellular CD31 immunostaining (n=8) (Day 3: 1.1±0.9 versus 1±0.4, P=0.27 and Day 7: 1.0±0.8 versus 1.8±1.4, *P=0.02) (B). Representative images of CD31 immunostaining at 40x (scale bar=0.05 mm) (C). Data were analyzed using a Mann-Whitney test comparison and presented as mean±SD.